OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension

NCT01642212 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Esophagitis (EoE)

Interventions

DRUG: Oral Budesonide Suspension (MB-9)
DRUG: Placebo

Sponsor

Shire